- Home
- WSBCP vs VCEL Comparison
WSBCP vs VCEL Comparison
Compare WSBCP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBCP
- VCEL
- Stock Information
- Founded
- WSBCP N/A
- VCEL 1989
- Country
- WSBCP United States
- VCEL United States
- Employees
- WSBCP 2195
- VCEL N/A
- Industry
- WSBCP Major Banks
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WSBCP Finance
- VCEL Health Care
- Exchange
- WSBCP Nasdaq
- VCEL Nasdaq
- Market Cap
- WSBCP N/A
- VCEL 2.1B
- IPO Year
- WSBCP N/A
- VCEL 1997
- Fundamental
- Price
- WSBCP $25.43
- VCEL $40.25
- Analyst Decision
- WSBCP
- VCEL Strong Buy
- Analyst Count
- WSBCP 0
- VCEL 8
- Target Price
- WSBCP N/A
- VCEL $62.00
- AVG Volume (30 Days)
- WSBCP N/A
- VCEL 477.0K
- Earning Date
- WSBCP N/A
- VCEL 07-31-2025
- Dividend Yield
- WSBCP N/A
- VCEL N/A
- EPS Growth
- WSBCP N/A
- VCEL 521.85
- EPS
- WSBCP N/A
- VCEL 0.05
- Revenue
- WSBCP N/A
- VCEL $238,541,000.00
- Revenue This Year
- WSBCP N/A
- VCEL $23.03
- Revenue Next Year
- WSBCP N/A
- VCEL $24.52
- P/E Ratio
- WSBCP N/A
- VCEL $780.58
- Revenue Growth
- WSBCP N/A
- VCEL 14.80
- 52 Week Low
- WSBCP N/A
- VCEL $37.39
- 52 Week High
- WSBCP N/A
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- WSBCP 69.65
- VCEL 44.06
- Support Level
- WSBCP $25.28
- VCEL $39.39
- Resistance Level
- WSBCP $25.24
- VCEL $42.61
- Average True Range (ATR)
- WSBCP 0.04
- VCEL 1.73
- MACD
- WSBCP 0.02
- VCEL -0.15
- Stochastic Oscillator
- WSBCP 100.00
- VCEL 24.16
About WSBCP WesBanco Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 6.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.